Effects of drugs of abuse on channelrhodopsin-2 function.

about

Effects of drugs of abuse on channelrhodopsin-2 function.

Item

http://www.wikidata.org/entity/Q52316872

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Effects of drugs of abuse on channelrhodopsin-2 function.

@en

Effects of drugs of abuse on channelrhodopsin-2 function.

@nl

type

Item

label

Effects of drugs of abuse on channelrhodopsin-2 function.

@en

Effects of drugs of abuse on channelrhodopsin-2 function.

@nl

prefLabel

Effects of drugs of abuse on channelrhodopsin-2 function.

@en

Effects of drugs of abuse on channelrhodopsin-2 function.

@nl

P1476

Effects of drugs of abuse on channelrhodopsin-2 function.

@en

P2093

Dominic A Gioia

http://www.w3.org/2001/XMLSchema#string

John J Woodward

http://www.w3.org/2001/XMLSchema#string

Minfu Xu

http://www.w3.org/2001/XMLSchema#string

Wesley N Wayman

http://www.w3.org/2001/XMLSchema#string

P2860

Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward

Channelrhodopsin-2, a directly light-gated cation-selective membrane channel

Human cannabinoid pharmacokinetics

Millisecond-timescale, genetically targeted optical control of neural activity

Mammalian ASIC2a and ASIC3 subunits co-assemble into heteromeric proton-gated channels sensitive to Gd3+

Detection of endogenous dopamine changes in Drosophila melanogaster using fast-scan cyclic voltammetry

Parvalbumin Interneurons of Central Amygdala Regulate the Negative Affective States and the Expression of Corticotrophin-Releasing Hormone During Morphine Withdrawal.

Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challenge

Review of toluene action: clinical evidence, animal studies and molecular targets.

Channelrhodopsin-2-assisted circuit mapping of long-range callosal projections.

P304

316-327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROPHARM.2018.03.031

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29580953

http://www.w3.org/2001/XMLSchema#string

P932

5975088

http://www.w3.org/2001/XMLSchema#string